Le Lézard
Classified in: Health, Covid-19 virus
Subject: SVY

Pharmaceutical Solvents Market Surges Amid Green Initiatives, Future Market Insights


DUBAI, UAE, July 16, 2020 /PRNewswire/ -- Award winning research firm Future Market Insights, in its recently published pharmaceutical solvents market research report, concludes that a revenue threshold of US$ 3.43 Bn will be crossed by 2030-end.

FMI_Logo

Pharmaceutical companies have exploited several chemical compositions to develop important formulations. As the desired compositions may not necessarily form chemical bonds, solvents are used to induce uniformity in these formulations.

Solvents are used to segregate, suspend, extract or dissolve different chemicals. They are used as excipients, active substances or building blocks during drug formulations. Additionally, solvents are also used as disinfectants in rinsing fluids.

These aforementioned applications of solvents is what catapults the market northwards. However, regulatory authorities have highlighted concerns regarding the residue which is left behind post-consumption.

These are generally toxic in nature, having detrimental impacts on human health should they come in contact. Excessive residues are also known to fast track the decomposition process of drugs. Therefore, manufacturers are exploring alternatives, particularly organic solvents as well as reduce the proportion of existing residual components to retain their market footing.

Growth of the market is slated to remain afloat during the COVID-19 pandemic. This is because pharmaceutical solvents are being extensively utilized to manufacture hand sanitizers.

As people become more wary of contracting the deadly infection, they are taking measures to ensure basic hygienic practices such as regular handwashing and cleaning of exposed surfaces. This has generated a tailwind in the demand for hand sanitizers, in households as well as business settings.

For more insights into the Market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1939

"Strict compliance with regulatory standards has spurred research into green chemistry. To that end, organic solvents based on acetone, ethanol and methanol formulations are being extensively used for tablet coatings. Market players are leaving no stone unturned to take advantage of this opportunity to enhance their revenue pools," infers an FMI analyst.

Key Takeaways from FMI's Pharmaceutical Solvents Report

Pharmaceutical Solvents Market- Key Trends

Pharmaceutical Solvents Market- Region-wise Analysis

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-1939

Pharmaceutical Solvents Market- Competitive Landscape

The global pharmaceutical solvents market is fairly consolidated, with prominent players developing advanced solubility technologies to augment revenue pools. Some of the leading players in the industry include Lyondell Basell Industries Holdings, the Dow Chemical Company, BASF SE, Bayer Group, Mitsui Chemicals and PPG Industries among others.

BASF SE is a pioneer in the pharmaceutical solvents market, producing solvents of the highest quality customized to specific needs. An example of its solvent includes the THF Pharma Super Dry which contains a maximum of 50 ppm water content, suitable for operations with high water-sensitive reactions.

The Dow Chemical Company offers propylene glycol pharmaceutical solvents having a production capacity of 900 kilo tons. The company has been conferred with awards which has enhanced its prestige and consequently monetary value in the global market. The company won the 2017 Green Chemistry Challenges by the US Environmental Protection Agency for producing greener chemicals.

Is Creating a Recession-Proof Business Possible? Read more at https://www.entrepreneur.com/article/353033

Pharmaceutical Solvents Market Taxonomy

Chemical Group

Region/Country

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East & Africa

Get full Report Now@ https://www.futuremarketinsights.com/checkout/1939

More Valuable Insights on Pharmaceutical Solvents Market

FMI, in its new market research study, offers an unbiased analysis of the pharmaceutical solvents market which comprises global industry analysis for 2015?2019 and opportunity assessment for the 2020?2030. The report offers complete analysis on global pharmaceutical solvents market through two different categories ? by chemical group and region. The study provides information on pricing through different application analysis, product life cycle, capacity assessment, key market trends and technologies which are being implemented in the deployment of pharmaceutical solvents and product adoption in varied end use industries.

Explore Extensive Coverage on FMI's Chemicals & Materials Landscape

Fluorinated Solvents Market: FMI's fluorinated solvents market offers a comprehensive analysis of the business models, key strategies and respective market shares of prominent market players through statistics in terms of revenue, segment-wise data, regional landscape and country-specific analysis from 2018 to 2028.

Polypropylene Market: The polypropylene market is slated to surge at a steady growth rate on the back of stable demand from end-use industries. For further details, peruse FMI's exhaustive study on the subject, elucidating on other prominent growth stimulators between 2020 and 2030.

Global Esters Market: Investigate FMI's deep coverage on the global esters market, bringing to the fore insights which will assist stakeholders identify the challenges and opportunities associated with market growth for the 2019-2029 assessment period.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously track emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: [email protected] 
For Media Enquiries: [email protected] 
Report: https://www.futuremarketinsights.com/reports/pharmaceutical-solvents-market 
Press Release Source: https://www.futuremarketinsights.com/press-release/pharmaceutical-solvents-market

 


These press releases may also interest you

at 09:25
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...

at 09:00
Amid growing concerns about a medical crisis as a result of acute conflict between the government...

at 08:45
Wolf Haldenstein Adler Freeman & Herz LLP  ("Wolf  Haldenstein") announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern  District of New York on behalf of investors who purchased...

at 08:00
Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, is happy to announce that its wholly owned generic pharmaceutical subsidiary, Nora...

at 07:00
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...

at 07:00
YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and...



News published on and distributed by: